Positives:
- NPAT within guidance
- No further downgrade
- Cash balance is still very strong. Less likelihood of shareholder dilution.
- 2H21 had reasonable momentum/rebound
- Dividend wasnt cut/reduced
Negatives
- Group revenue down 11%2, EBITDA3 down 15%2, and adjustedNPATdown19%2. Group EBITDAmargin3 down to 20%
- Still uncertainty with outlook due to covid.
- CEO transiton
- overall report feels a little underwhelming.
really hard to anticipate what happens today and short term. I guess more downside, then up.
Ann: FY21 Results Announcement, page-10
Add BVS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.008(0.65%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.19 | $1.15 | $581.0K | 500.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 10425 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 15760 | 23 |
View Market Depth
| Last trade - 14.06pm 17/07/2024 (20 minute delay) ? |
| BVS (ASX) Chart |